TORONTO—Moderna says upcoming clinical trials for its COVID-19 vaccine will include Canadian children.
The company announced details of its Phase 2/3 study of COVID-19 earlier this week. It’s expected to involve 6,750 healthy pediatric participants aged six months to 12 years.